Axsome Therapeutics, Inc. stands as a biopharmaceutical firm dedicated to developing innovative treatments for central nervous system (CNS) conditions within the United States. The company’s portfolio features marketed products including Au…
HQ: New York City, NY, United States of Americawww.axsome.com
USD220.75+4.56%vs prev. close
Market snapshot
Price
USD220.75
Daily move
+4.56%
P/E
—
EPS TTM
-3.75
Dividend yield
—
Beta
0.71
Market cap
11.6B
Price history
AXSM price
USD
No price history available
Next earnings
No upcoming earnings report scheduled in the next 6 months.
Peer comparison
Company
Ticker
Industry
Mkt cap (USD bn)
P/E
Div yld
1W
1M
3M
6M
1Y
YTD
Axsome Therapeutics
AXSM
Biotechnology
11.6
—
—
+6.8%
+2.8%
-13.5%
+41.4%
+79.5%
+20.9%
🔒
Subscribe to Equity Analytics to compare AXSM with its closest peers
Sector-matched peer set with side-by-side valuation, dividend and performance over every window.